Woodline Partners’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.18M Hold
145,704
﹤0.01% 863
2025
Q4
$1.51M Hold
145,704
0.01% 807
2025
Q3
$1.29M Hold
145,704
0.01% 781
2025
Q2
$841K Hold
145,704
﹤0.01% 819
2025
Q1
$962K Sell
145,704
-27,000
-16% -$210K 0.01% 767
2024
Q4
$1.5M Buy
172,704
+29,497
+21% +$424K 0.01% 697
2024
Q3
$2.8M Hold
143,207
0.02% 445
2024
Q2
$2.95M Buy
+143,207
New +$2.94M 0.03% 387
2023
Q3
Sell
-867,062
Closed -$9.17M 681
2023
Q2
$9.17M Buy
867,062
+377,530
+77% +$4.47M 0.11% 216
2023
Q1
$5.99M Buy
+489,532
New +$6.11M 0.08% 264
2022
Q4
Sell
-267,683
Closed -$3.66M 809
2022
Q3
$3.66M Hold
267,683
0.05% 351
2022
Q2
$4.91M Hold
267,683
0.08% 263
2022
Q1
$4.3M Hold
267,683
0.07% 261
2021
Q4
$3.75M Hold
267,683
0.05% 323
2021
Q3
$5.01M Hold
267,683
0.08% 248
2021
Q2
$5.58M Buy
+267,683
New +$6.65M 0.1% 208

Other funds holding KURA